Literature DB >> 9630599

Functional genetic tests of DNA mismatch repair protein activity in Saccharomyces cerevisiae.

P Polaczek1, A P Putzke, K Leong, G A Bitter.   

Abstract

Hereditary non-polyposis colorectal cancer (HNPCC) is associated with mutations in four different genes encoding proteins involved in DNA mismatch repair (DMR). As many as 30% of the observed sequence variations in human DMR genes predict minor alterations in the encoded protein, such as amino acid (aa) replacements or small in-frame deletions/insertions. For such sequence variants, a functional genetic test will be required to discriminate mutations from polymorphisms. We have constructed a series of isogenic yeast strains in which individual genes involved in DMR are disrupted, and have standardized an assay which measures GT tract stability (Strand et al., 1993) to characterize these gene products. Disruptions of the yeast MSH2, MLH1, and PMS1 genes result in, respectively, a 290-, 450- and 390-fold increased tract instability over the wild type (wt) strain under optimized assay conditions. Expression of the wt MSH2 and PMS1 gene from plasmids results in complementation of the corresponding chromosomal gene disruption. Two different aa replacements which correspond to previously observed sequence variants of the human MSH2 gene, and implicated in HNPCC, were created in the conserved aa of the yeast MSH2 gene by site directed mutagenesis. Conversion of the Pro640 in the yeast protein to Leu resulted in a complete loss of protein function. In contrast, a yeast MSH2p protein in which the His658 is changed to Tyr retains full function in this in vivo assay. These results indicate that the Pro-->Leu and His-->Tyr variants observed in humans constitute, respectively, a mutation and a polymorphism. The system described here may be used for further structure/function analysis of yeast DMR proteins. Such studies may provide insight into the effects that specific sequence variations observed in human DMR proteins have on their function. Copyright 1998 Elsevier Science B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630599     DOI: 10.1016/s0378-1119(98)00150-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization.

Authors:  Samuele Lodovichi; Martina Vitello; Tiziana Cervelli; Alvaro Galli
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

2.  Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch Syndrome: a functional analysis report.

Authors:  Matjaz Vogelsang; Radovan Komel
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

3.  Assessment of functional effects of unclassified genetic variants.

Authors:  Fergus J Couch; Lene Juel Rasmussen; Robert Hofstra; Alvaro N A Monteiro; Marc S Greenblatt; Niels de Wind
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

4.  Distinct requirements within the Msh3 nucleotide binding pocket for mismatch and double-strand break repair.

Authors:  Charanya Kumar; Gregory M Williams; Brett Havens; Michelle K Dinicola; Jennifer A Surtees
Journal:  J Mol Biol       Date:  2013-02-28       Impact factor: 5.469

Review 5.  Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.

Authors:  Christopher D Heinen
Journal:  Mutat Res       Date:  2009-09-17       Impact factor: 2.433

6.  Human MutL homolog (MLH1) function in DNA mismatch repair: a prospective screen for missense mutations in the ATPase domain.

Authors:  Aaron R Ellison; Joan Lofing; Grant A Bitter
Journal:  Nucleic Acids Res       Date:  2004-10-08       Impact factor: 16.971

7.  Functional characterization of pathogenic human MSH2 missense mutations in Saccharomyces cerevisiae.

Authors:  Alison E Gammie; Naz Erdeniz; Julia Beaver; Barbara Devlin; Afshan Nanji; Mark D Rose
Journal:  Genetics       Date:  2007-08-24       Impact factor: 4.562

8.  Determining the functional significance of mismatch repair gene missense variants using biochemical and cellular assays.

Authors:  Christopher D Heinen; Lene Juel Rasmussen
Journal:  Hered Cancer Clin Pract       Date:  2012-07-23       Impact factor: 2.857

9.  Assessing pathogenicity of MLH1 variants by co-expression of human MLH1 and PMS2 genes in yeast.

Authors:  Matjaz Vogelsang; Aleksandra Comino; Neja Zupanec; Petra Hudler; Radovan Komel
Journal:  BMC Cancer       Date:  2009-10-28       Impact factor: 4.430

10.  The G67E mutation in hMLH1 is associated with an unusual presentation of Lynch syndrome.

Authors:  M Clyne; J Offman; S Shanley; J D Virgo; M Radulovic; Y Wang; A Ardern-Jones; R Eeles; E Hoffmann; V P C C Yu
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.